From Cardiff, United Kingdom:
I have had type 1 diabetes for the past 12 years, and to be honest, have only recently been accepting of the consequences of bad control. My last A1c was 11% and has been around that level since diagnosis, despite varied routines.
At the moment, I am following a fairly low carb diet, which I know is not the norm, but I am fed up with constantly high blood sugars (11-13 mmol/L [198-234 mg/dl]). The response has always been to increase my insulin levels, but even then my sugar levels did not seem to go down. I am finding it very hard to get across to my diabetes team that I do not binge on sugary foods. Is it possible that I have an insulin intolerance as well as Type 1 diabetes since I also have PCOS? For instance today, I have taken my insulin, and have not eaten any carbohydrate at all, but my sugars have been steadily high all day? I want to avoid taking high levels of insulin as it exacerbates my PCOS. Is it possible that I have an insulin intolerance as well as type 1 diabetes since I also have PCOS?
I feel no ill effects of my diabetes, but know that I must get my levels under control to continue to enjoy my problem free life.
If you really have Polycystic Ovary Syndrome, you have insulin resistance, and maybe both type 1 and type 2 diabetes. Ask your doctor about using Glucophage [metformin] (up to 2 grams a day) as another treatment. I would believe it will improve insulin resistance and make things better.
Last Updated: Tuesday April 06, 2010 15:09:34
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
© Children with Diabetes, Inc. 1995-2017. Comments and Feedback.